Strs Ohio cut its stake in shares of Teleflex Incorporated (NYSE:TFX) by 0.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,569 shares of the medical technology company’s stock after selling 68 shares during the period. Strs Ohio’s holdings in Teleflex were worth $3,234,000 as of its most recent SEC filing.
A number of other institutional investors have also bought and sold shares of TFX. Asset Planning Services Ltd. acquired a new position in Teleflex during the first quarter valued at approximately $116,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new position in Teleflex during the first quarter valued at approximately $155,000. OLD Mutual Customised Solutions Proprietary Ltd. raised its position in Teleflex by 200.0% in the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 900 shares of the medical technology company’s stock valued at $174,000 after buying an additional 600 shares during the period. Campbell & CO Investment Adviser LLC acquired a new position in Teleflex during the second quarter valued at approximately $200,000. Finally, Harvey Capital Management Inc. acquired a new position in Teleflex during the second quarter valued at approximately $207,000. 92.59% of the stock is currently owned by hedge funds and other institutional investors.
Teleflex Incorporated (NYSE TFX) traded down 0.59% during trading on Friday, reaching $210.66. 174,889 shares of the company’s stock traded hands. The stock has a 50-day moving average price of $210.06 and a 200 day moving average price of $198.54. Teleflex Incorporated has a 1-year low of $136.53 and a 1-year high of $217.97. The stock has a market capitalization of $9.49 billion, a P/E ratio of 40.29 and a beta of 1.05.
Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.91 by $0.13. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The business had revenue of $528.60 million during the quarter, compared to analyst estimates of $518.98 million. During the same period in the previous year, the business posted $1.89 EPS. The company’s quarterly revenue was up 11.6% on a year-over-year basis. Equities research analysts expect that Teleflex Incorporated will post $8.28 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Stockholders of record on Tuesday, August 15th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.65%. The ex-dividend date is Friday, August 11th. Teleflex’s dividend payout ratio (DPR) is presently 26.00%.
COPYRIGHT VIOLATION WARNING: This news story was posted by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://www.com-unik.info/2017/08/19/strs-ohio-sells-68-shares-of-teleflex-incorporated-tfx-updated.html.
Several equities analysts recently commented on the company. BidaskClub lowered Teleflex from a “hold” rating to a “sell” rating in a report on Tuesday, August 8th. Jefferies Group LLC reissued a “buy” rating and issued a $230.00 target price on shares of Teleflex in a report on Thursday, August 3rd. Deutsche Bank AG reissued a “buy” rating and issued a $238.00 target price (up previously from $220.00) on shares of Teleflex in a report on Wednesday, August 9th. Needham & Company LLC restated a “buy” rating on shares of Teleflex in a research note on Friday, August 4th. Finally, Zacks Investment Research downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Thursday, June 22nd. One analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $228.00.
In other Teleflex news, Director Stuart A. Randle sold 2,500 shares of the business’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $205.67, for a total transaction of $514,175.00. Following the completion of the transaction, the director now directly owns 7,532 shares of the company’s stock, valued at approximately $1,549,106.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Stephen K. M.D. Klasko sold 200 shares of the business’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $208.41, for a total transaction of $41,682.00. Following the transaction, the director now directly owns 8,080 shares of the company’s stock, valued at $1,683,952.80. The disclosure for this sale can be found here. Insiders sold a total of 3,100 shares of company stock valued at $637,463 over the last ninety days. Company insiders own 2.39% of the company’s stock.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
What are top analysts saying about Teleflex Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Teleflex Incorporated and related companies.